Neogen NEOG 2026Q1 Earnings Preview Upside Ahead on Revised Guidance
Generated by AI AgentAinvestweb
Monday, Oct 6, 2025 7:12 pm ET1min read
NEOG--
Forward-Looking Analysis
Analysts expect Neogen’s 2026Q1 earnings to show improvement, with Zacks Research forecasting an EPS of $0.11. This aligns with the company’s updated full-year 2025 guidance, which projected revenue between $905 million and $925 million. Neogen’s Q4 2025 results, while showing a net loss of $612.2 million due to non-cash goodwill impairment, included an adjusted net income of $11.3 million and EPS of $0.05—266.67% above the forecasted -$0.03. Adjusted EBITDA for Q4 was $40.6 million. With positive momentum in adjusted metrics and guidance for continued revenue growth, the path for 2026Q1 appears favorable.
Historical Performance Review
In Q4 2025, NeogenNEOG-- reported revenue of $225.46 million but incurred a net loss of $612.20 million, with an EPS of -$2.82. The loss was primarily driven by a non-cash goodwill impairment. Gross profit stood at $92.86 million. Despite the net loss, the company’s adjusted net income was $11.3 million, with an EPS of $0.05—well above the forecast.
Additional News
Neogen’s Q3 2025 results showed revenue of $221.0 million and a net loss of $11.0 million ($-0.05 EPS), though adjusted net income was $20.9 million ($0.10 EPS). The company updated its full-year 2025 revenue guidance to $905–$925 million. Zacks Research also projected Q4 2025 EPS at $0.09 and Q2 2026 EPS at $0.11. The Q4 earnings call transcript highlighted the strong performance relative to forecasts, with adjusted metrics beating expectations.
Summary & Outlook
Neogen’s financial performance in 2025 has been mixed, marked by a significant net loss due to non-cash impairments but strong adjusted earnings. The company’s revenue remains stable, with Q4 at $225.5 million and full-year guidance of $905–$925 million. Gross profit and adjusted EBITDA highlight operational strength. With a Q2 2026 EPS forecast of $0.11 and improved guidance, the outlook is cautiously optimistic. While earnings volatility remains a risk, Neogen’s strong revenue and adjusted metrics suggest a potentially bullish path ahead.
Analysts expect Neogen’s 2026Q1 earnings to show improvement, with Zacks Research forecasting an EPS of $0.11. This aligns with the company’s updated full-year 2025 guidance, which projected revenue between $905 million and $925 million. Neogen’s Q4 2025 results, while showing a net loss of $612.2 million due to non-cash goodwill impairment, included an adjusted net income of $11.3 million and EPS of $0.05—266.67% above the forecasted -$0.03. Adjusted EBITDA for Q4 was $40.6 million. With positive momentum in adjusted metrics and guidance for continued revenue growth, the path for 2026Q1 appears favorable.
Historical Performance Review
In Q4 2025, NeogenNEOG-- reported revenue of $225.46 million but incurred a net loss of $612.20 million, with an EPS of -$2.82. The loss was primarily driven by a non-cash goodwill impairment. Gross profit stood at $92.86 million. Despite the net loss, the company’s adjusted net income was $11.3 million, with an EPS of $0.05—well above the forecast.
Additional News
Neogen’s Q3 2025 results showed revenue of $221.0 million and a net loss of $11.0 million ($-0.05 EPS), though adjusted net income was $20.9 million ($0.10 EPS). The company updated its full-year 2025 revenue guidance to $905–$925 million. Zacks Research also projected Q4 2025 EPS at $0.09 and Q2 2026 EPS at $0.11. The Q4 earnings call transcript highlighted the strong performance relative to forecasts, with adjusted metrics beating expectations.
Summary & Outlook
Neogen’s financial performance in 2025 has been mixed, marked by a significant net loss due to non-cash impairments but strong adjusted earnings. The company’s revenue remains stable, with Q4 at $225.5 million and full-year guidance of $905–$925 million. Gross profit and adjusted EBITDA highlight operational strength. With a Q2 2026 EPS forecast of $0.11 and improved guidance, the outlook is cautiously optimistic. While earnings volatility remains a risk, Neogen’s strong revenue and adjusted metrics suggest a potentially bullish path ahead.
This internal account is for our software. It'll answer users' questions about subscription products, aiming to boost adoption and retention.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet